BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gonzaga IM, Soares Lima SC, Nicolau MC, Nicolau-Neto P, da Costa NM, de Almeida Simão T, Hernandez-Vargas H, Herceg Z, Ribeiro Pinto LF. TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells. Clin Epigenetics 2017;9:130. [PMID: 29296124 DOI: 10.1186/s13148-017-0429-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Khan T, Relitti N, Brindisi M, Magnano S, Zisterer D, Gemma S, Butini S, Campiani G. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas. Med Res Rev 2020;40:1002-60. [PMID: 31742748 DOI: 10.1002/med.21646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
2 Li J, Zhu H, Yang Q, Xiao H, Wu H, Fang Z, Li W, Cai M, Wang F. Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m6A Regulators. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5490461] [Reference Citation Analysis]
3 Soares-Lima SC, Gonzaga IM, Camuzi D, Nicolau-Neto P, Vieira da Silva R, Guaraldi S, Ferreira MA, Hernandez-Vargas H, Herceg Z, Ribeiro Pinto LF. IL6 and BCL3 Expression Are Potential Biomarkers in Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:722417. [PMID: 34422669 DOI: 10.3389/fonc.2021.722417] [Reference Citation Analysis]
4 Businello G, Parente P, Mastracci L, Pennelli G, Traverso G, Milione M, Bellan E, Michelotto M, Kotsafti A, Grillo F, Fassan M. The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis. Cancers (Basel) 2020;12:E2160. [PMID: 32759723 DOI: 10.3390/cancers12082160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhou Y, Xu S, Liu J, Zhu Y, Zhu Y, Li W, Ling H. Gastrokine 2 Regulates the Antitumor Effect of JAK2/STAT3 Pathway in Gastric Cancer. Evid Based Complement Alternat Med 2021;2021:1343808. [PMID: 34381519 DOI: 10.1155/2021/1343808] [Reference Citation Analysis]
6 Salta S, Macedo-Silva C, Miranda-Gonçalves V, Lopes N, Gigliano D, Guimarães R, Farinha M, Sousa O, Henrique R, Jerónimo C. A DNA methylation-based test for esophageal cancer detection. Biomark Res 2020;8:68. [PMID: 33292587 DOI: 10.1186/s40364-020-00248-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jin YQ, Miao DL. Multiomic Analysis of Methylation and Transcriptome Reveals a Novel Signature in Esophageal Cancer. Dose Response 2020;18:1559325820942075. [PMID: 32728353 DOI: 10.1177/1559325820942075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Tang L, Liou Y, Wan Z, Tang J, Zhou Y, Zhuang W, Wang G. Aberrant DNA methylation of PAX1, SOX1 and ZNF582 genes as potential biomarkers for esophageal squamous cell carcinoma. Biomedicine & Pharmacotherapy 2019;120:109488. [DOI: 10.1016/j.biopha.2019.109488] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
9 Qin Y, Zhou J, Fan Z, Gu J, Li X, Lin D, Deng D, Wei W. Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy. Front Oncol 2021;11:683876. [PMID: 34485122 DOI: 10.3389/fonc.2021.683876] [Reference Citation Analysis]